Tarick Elayan, NP
Nurse Practitioner · Farmington Hills, MINPI 1922747054
Payments from drug & device makers
Across 155 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$859
- GSK$488
- AbbVie$291
- Pfizer$201
- Cequr Corporation$161
- plus $749 from 14 others
What the payments were for
- Food & beverage$3,862100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $1,112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $859 |
| GSK | 24 | $488 |
| AbbVie | 12 | $291 |
| Pfizer | 11 | $201 |
| Cequr Corporation | 1 | $161 |
| Ironwood Pharmaceuticals, Inc | 7 | $135 |
| Lilly USA, LLC | 7 | $116 |
| Boehringer Ingelheim | 4 | $81 |
| Mylan Specialty L.p. | 3 | $75 |
| Novo Nordisk | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Exact Sciences | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Orexo US, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$250
- CAPLYTA$248
- CeQur Simplicity$161
- VRAYLAR$125
- LOKELMA$110
How this compares
$3,862 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 126 | $94,107 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 139 | $87,928 |
| EliquisApixaban | 40 | $38,402 |
| TrulicityDulaglutide | 39 | $37,813 |
| MounjaroTirzepatide | 31 | $30,213 |
| XareltoRivaroxaban | 21 | $22,346 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 31 | $19,759 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 94 | $16,599 |
| LinzessLinaclotide | 27 | $14,511 |
| OzempicSemaglutide | 15 | $13,905 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $8,761 |
| FarxigaDapagliflozin Propanediol | 13 | $8,553 |
| EntrestoSacubitril/Valsartan | 12 | $7,897 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,570 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 266 | $7,531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $81 | $94,107126 claims |
| GSKTrelegy Ellipta | $488 | $87,928139 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $116 | $68,02670 claims |
| PfizerEliquis | $201 | $38,40240 claims |
| Indivior Inc.Suboxone | $18 | $19,75931 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,112 | $16,12325 claims |
| AbbVieLinzess | $291 | $14,51127 claims |
| Novo NordiskOzempic | $70 | $13,90515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Farmington Hills
- Carla FerriseFarmington Hills$41K
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.